MedTrace Logo

Urinary Steroid Metabolites in Autism

NCT01197131 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 160

Last updated 2019-02-19

No results posted yet for this study

Summary

Deviation of hormone formation within nerve cells and nerve system provides autism spectrum disorder and neurodevelopment retardation through interaction of steroids with neurotransmitter-receptors, calcium-channel receptors and genomic interaction via nuclear steroid receptors.

Urinary steroid metabolites will be compared between children with autism spectrum disorder and healthy controls.

Conditions

Sponsors & Collaborators

  • Intersci Research Association, Austria

    lead OTHER

Principal Investigators

  • Johann Kurz, MD · Intersci Research Association, Austria

Eligibility

Min Age
5 Years
Max Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2011-07-31
Completion
2019-04-30

Countries

  • Austria

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01197131 on ClinicalTrials.gov